AgeX Therapeutics, Inc AGE

AgeX Therapeutics, Inc

Biotechnology

Healthcare

AGE

38.00M shares

NYSE MKT US

traded

05 Aug 2021

open

1.37

52 week high

2.70

high

1.37

52 week low

0.79

low

1.32

growth

3.1%

previous Close

1.35

P/E ratio

-24

market cap

56.91M

div yield

0

usd

Mar 2021

qoq

revenue

56.00K

-88.91 %

net incoming

-2.09M

81,558.19 %

eps

-0.06

4.73 %

eps surprise

0.00 %

net profit margin

-3728.57 %

-3728.00 %

operating incoming

-2.19M

89,274.74 %

net change in cash

282K

-144.76 %

cash on hand

809K

53.51 %

cost of revenue

3.00K

-92.11 %